Abstract
Vedolizumab is a selective immuno-suppressive monoclonal antibody. It is now available for the treatment of ulcerative colitis and Crohn's disease.(c)......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
